McCollum Christoferson Group LLC Makes New Investment in Virios Therapeutics, Inc. (NASDAQ:VIRI)

McCollum Christoferson Group LLC acquired a new stake in Virios Therapeutics, Inc. (NASDAQ:VIRI – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 30,700 shares of the company’s stock, valued at approximately $42,000. A number of other hedge funds […]

Related Keywords

Gregory Scott Duncan ,Renaissance Technologies ,Mccollum Christoferson Group ,Exchange Commission ,Vanguard Group Inc ,Virios Therapeutics Inc ,Susquehanna International Group ,Envestnet Asset Management Inc ,Virios Therapeutics Company Profile ,Nasdaq ,Securities Exchange Commission ,Virios Therapeutics ,Free Report ,International Group ,Asset Management ,Get Free Report ,Scott Duncan ,Visit Holdingschannel ,Virios Therapeutics Daily ,Nasdaq Viri ,Loviri ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,